Loading…
Loading…
REGN · NASDAQ · Healthcare
“When you find a medicine maker earning $43 per share trading at seventeen times earnings, that's the kind of reasonable price tag I can understand.”
— In the voice of Buffett
Calculate total returns over 1, 3, 5, and 10-year periods. Understand long-term compounding and investment outcomes.
Market Cap
$78.21B
P/E Ratio
17.36
Forward P/E
—
EPS
$43.07
PEG Ratio
-4.94
Book Value
$298.82
Dividend Yield
0.48%
Profit Margin
31.41%
ROE
14.41%
Use the interactive multi-year return with pre-loaded data for Regeneron Pharmaceuticals Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for REGN: